Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY1 | P47900 | 7/20 | 0.92 |
| ▸ | P2RY2 | P41231 | 3/20 | 0.92 |
| ▸ | SRC | P12931 | 2/20 | 0.92 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.92 |
| ▸ | P2RX1 | P51575 | 2/20 | 0.92 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.92 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.92 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.92 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.92 |
| ▸ | TRPM2 | O94759 | 2/20 | 0.88 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.88 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.88 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.88 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.88 |
| ▸ | LDHA | P00338 | 1/20 | 0.88 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.88 |
| ▸ | FBP1 | P09467 | 1/20 | 0.88 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.88 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.88 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.88 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3046222 | 1.00 | P2RY1 (0.92) | P2RY1P2RY2SRCSMN1; SMN2P2RX1 | |
| Diadenosine Tetraphosphate SCHEMBL14205963 | 0.96 | P2RY1 (1.00) | P2RY1P2RY2SRCSMN1; SMN2P2RX1 | |
| Diadenosine Tetraphosphate SCHEMBL849869 | 0.96 | P2RY1 (1.00) | P2RY1P2RY2SRCSMN1; SMN2P2RX1 | |
| SCHEMBL6516963 | 0.96 | P2RY1 (1.00) | P2RY1P2RY2SRCSMN1; SMN2P2RX1 | |
| SCHEMBL4357990 | 0.96 | P2RY1 (1.00) | P2RY1P2RY2SRCSMN1; SMN2P2RX1 | |
| SCHEMBL1744586 | 0.96 | P2RY1 (1.00) | P2RY1P2RY2SRCSMN1; SMN2P2RX1 | |
| Diadenosine Tetraphosphate SCHEMBL4363130 | 0.96 | P2RY1 (1.00) | P2RY1P2RY2SRCSMN1; SMN2P2RX1 | |
| Diadenosine Tetraphosphate SCHEMBL4069414 | 0.96 | P2RY1 (1.00) | P2RY1P2RY2SRCSMN1; SMN2P2RX1 | |
| SCHEMBL21067711 | 0.96 | P2RY1 (1.00) | P2RY1P2RY2SRCSMN1; SMN2P2RX1 | |
| SCHEMBL2934890 | 0.96 | P2RY1 (1.00) | P2RY1P2RY2SRCSMN1; SMN2P2RX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11643439-B2 | Multi-target compound with anticoagulation and antiplatelet activity, preparation method therefor, and use thereof | SHAANXI MICOT TECHNOLOGY LIMITED COMPANY (CN) | 2023-05-09 | — | — | US | disclosed |
| CN-113423418-A | Treatment of cilia disease | 埃泽瑞斯公司 | 2021-09-21 | — | — | CN | disclosed |
| EP-3333177-B1 | MULTI-TARGET COMPOUND WITH ANTICOAGULATION AND ANTIPLATELET ACTIVITY, PREPARATION METHOD THEREFOR, AND USE THEREOF | SHAANXI MICOT TECH LIMITED COMPANY (CN) | 2021-07-14 | — | — | EP | disclosed |
| EP-3600245-A1 | METHOD FOR PRODUCING A LIQUID COMPOSITION | The University of Liverpool (GB) | 2020-02-05 | — | — | EP | disclosed |
| US-20180305409-A1 | MULTI-TARGET COMPOUND WITH ANTICOAGULATION AND ANTIPLATELET ACTIVITY, PREPARATION METHOD THEREFOR, AND USE THEREOF | Shaanxi Micot Pharmaceutical Technology Co., Ltd. (CN) | 2018-10-25 | — | — | US | disclosed |
| WO-2018178721-A1 | METHOD FOR PRODUCING A LIQUID COMPOSITION | THE UNIVERSITY OF LIVERPOOL (GB) | 2018-10-04 | — | — | WO | disclosed |
| EP-3333177-A1 | MULTI-TARGET COMPOUND WITH ANTICOAGULATION AND ANTIPLATELET ACTIVITY, PREPARATION METHOD THEREFOR, AND USE THEREOF | Shaanxi Micot Technology Limited Company (CN) | 2018-06-13 | — | — | EP | disclosed |
| EP-1986665-A2 | MICROALGAE-DERIVED COMPOSITIONS FOR IMPROVING THE HEALTH AND APPEARANCE OF SKIN | Solazyme, Inc. (US) | 2008-11-05 | — | — | EP | disclosed |
| WO-2007084769-A2 | MICROALGAE-DERIVED COMPOSITIONS FOR IMPROVING THE HEALTH AND APPEARANCE OF SKIN | SOLAZYME, INC. (US) | 2007-07-26 | — | — | WO | disclosed |